John Wahren

Chief Tech/Sci/R&D Officer at Creative Peptides Sweden AB

Health Technology

Consumer Services

Profile

John Wahren was the founder of Cebix, Inc. which was founded in 2008, where he held the title of Director & Chief Scientific Officer from 2010 to 2014.
He is currently employed as an Emeritus Professor-Clinical Physiology at Karolinska Institutet and as Chief Scientific Officer at Creative Peptides Sweden AB.
Dr. Wahren's former position was as a Professor at the University of Lausanne in 1984.
He obtained his doctorate degree from Karolinska Institutet.

John Wahren active positions

Companies	Position	Start
Creative Peptides Sweden AB Creative Peptides Sweden AB Pharmaceuticals: MajorHealth Technology Creative Peptides Sweden AB develops and manufactures drugs. The company discovers and develops biopharmaceutical drugs to treat complications of Type 1 diabetes. It was founded in 1996 and is headquartered in Stockholm, Sweden.	Chief Tech/Sci/R&D Officer	-
Karolinska Institutet	Corporate Officer/Principal	2009-06-23

All active positions of John Wahren

Former positions of John Wahren

Companies	Position	End
University of Lausanne	Corporate Officer/Principal	1983-12-31
Cebix, Inc. Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA.	Founder	-

See the detail of John Wahren's experience

Training of John Wahren

Karolinska Institutet

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Wahren's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Creative Peptides Sweden AB Creative Peptides Sweden AB Pharmaceuticals: MajorHealth Technology Creative Peptides Sweden AB develops and manufactures drugs. The company discovers and develops biopharmaceutical drugs to treat complications of Type 1 diabetes. It was founded in 1996 and is headquartered in Stockholm, Sweden.	Health Technology
Cebix, Inc. Cebix, Inc. Pharmaceuticals: MajorHealth Technology Cebix, Inc. provided treatments for complications of diabetes. It developed Ersatta, a proprietary disease-modifying replacement peptide for the treatment of complications associated with diabetes, including diabetic peripheral neuropathy, autonomic neuropathy, nephropathy, and retinopathy. The company was founded by John Wahren and Lars G. Ekman in 2008 and was headquartered in San Diego, CA.	Health Technology